.jpg "Phillip Ramsey, M.S., M.B.A., R.A.C. photo")
CTO and SVP Technical Operations
Sangamo Therapeutics
Phillip Ramsey is SVP of Technical Operations at Sangamo where he oversees manufacturing, technical development, supply chain, and quality. He was previously the Vice President of Technical Development. Phillip has over 35 years of experience in product development, operations, and quality.
Prior to Sangamo Phillip was with Emergent BioSolutions in increasing roles of responsibility most recently Senior Director in the Biodefense division and helped design and facilitate construction of their CIADM facility, which was awarded the runner-up 2018 FOYA award for innovative design. While at Emergent he was involved with multiple commercial products, M&A activities, and their CDMO business.
Prior to this he was at Leidos where he helped design and construction a 130,000 sq.ft. vaccine pilot plant for the NIH. He has contributed to multiple regulatory submissions for product approval and more than 50 investigational new drug submissions.
Phillip received a BS in Chemistry from the University of Nebraska, a MS in Biochemistry from John Hopkins University and MBA from San Diego State University. He has experience in multiple therapeutic areas including oncology, vaccines, infectious diseases, CNS, and rare diseases. He has worked on a variety of technologies including proteins, monoclonal antibodies, cell/gene therapy, genome editing, LNPs, and Mabs.